Skip to main content

Drug Safety

RheumNow Podcast – ACR 2019  Round Up (11.15.19)
Dr. Jack Cush presents his favorite abstracts and presentations from Rheumatology Round Up and ACR 2019.
  • #1223 ALLN-346 a urate degrading enzyme in a pig model of gout
  • #L06 Emapalumab for treating MAS in systemic JIA patients
  • #1890 and 2357 Methotrexate Safety from CIRT
  • #1240 Anakinra in acute gout – anaGO study
  • #2292, #2279 When to withdraw biologics in RA patients who become pregnant
  • #633, #631 Delays in referral of LBP
  • #196 VTE risk and future ASCVD risk
  • #2566 Polypharmacy
  • #860 EMBRACE – Belimumab in Blacks
Panel Presentation: Psoriatic Arthritis

Drs. Eric Ruderman, Alexis Ogdie, Jessica Walsh, and Jose Scher discuss the giselkumab trials, where IL-23 inhibitors fit in practice, ixekizumab withdrawal, and more that presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Panel Presentation: Spondyloarthritis

Drs. Jack Cush, Christopher Ritchlin, Sophia Ramiro, Lianne Gensler, and Jessica Walsh discuss interesting new trials and data presented in ankylosing spondylitis and spondyloarthritis at the 2019 ACR/ARP annual meeting in Atlanta.  

Panel Presentation: Gout

Drs. Jack Cush, Nicola Dalbreth, Ken Saag and Robert Keenan discuss several gout presentations, including tart cherry, safety and efficacy of therapies, quality of life issues and more at the 2019 ACR/ARP annual meeting in Atlanta. 

Lupus Pearls: Dr. Kathryn Dao

Dr. Dao reviews several lupus pearls delivered by Dr. Michelle Petri at the 2019 ACR/ARP annual meeting in Atlanta. 

Tofacitinib as Monotherapy Following MTX Withdrawal in PsA: Dr. Eric Ruderman

Dr. Ruderman describes abstract #L14 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

SJIA-associated ILD: Dr. Jonathan Hausmann

Dr. Hausmann describes a new inflammatory lung disease at the 2019 ACR/ARP annual meeting in Atlanta. 

Rheumatology Pearls from Dr. Sterling West: Dr. Kathryn Dao

Dr. Dao shares pearls presented by Dr. West at the 2019 ACR/ARP annual meeting in Atlanta. 

Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau

Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

New Treatments for Axial Spondyloarthritis: Dr. Antoni Chan

Dr. Chan discusses several studies on spondyloarthritis presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Ixekizimab Withdrawal in PSA: Dr. Eric Ruderman

Dr. Ruderman highlights abstract #1532 at the 2019 ACR/ARP annual meeting in Atlanta.

TULIP Trials in Lupus: Dr. Mike Putman

Dr. Putman discusses abstracts # L17 and 1763 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Comparison of Ixekizumab and Adalimumab in PsA: Dr. Olga Petryna

Dr. Petryna discusses abstract #L20 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Overview of Several Gout Studies: Dr. Philip Robinson

Dr. Robinson highlights a number of gout-related abstracts, including #1236, #1217, #1218, #1235, at the ACR/ARP annual meeting in Atlanta. 

Subcutaneous Biosimilar: Dr. Jonathan Kay

Dr. Kay highlights abstract #548 presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Dr. Janet Pope: Drug Levels Associated with Lupus Flares

Dr. Pope discusses abstract #2567 Prospective Evaluation of American Academy of Ophthalmology Low Dose Hydroxychloroquine Recommendation in Stable Lupus Nephritis with High-Risk Retinopathy: Lipid Profile and Flare Rates presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Safety of Methotrexate (The CIRT Trial): Dr. Jack Cush

Dr. Cush discusses abstract #1890 on the CIRT trial as presented at the 2019 ACR/ARP annual meeting in Atlanta. 

Panel Presentation: What's New in iRAEs

Drs. Laura Cappelli, Len Calabrese and Cassandra Calabrese discuss presentations on iRAEs at the 2019 ACR/ARP annual meeting in Atlanta. 

Inflammatory Arthritis Persists After Immunotherapy Cessation: Dr. David Liew

Dr. Liew discusses abstract #1808 Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation presented at the 2019 ACR/ARP Annual Meeting in Atlanta. 

×